The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ibuprofen Farmalider 200 mg film-coated tablets

Farmalider, S.A.PA2090/002/001

Main Information

Trade NameIbuprofen Farmalider 200 mg film-coated tablets
Active SubstancesIbuprofen ph. eur.
Dosage FormFilm-coated tablet
Licence HolderFarmalider, S.A.
Licence NumberPA2090/002/001

Group Information

ATC CodeM01AE Propionic acid derivatives
M01AE01 ibuprofen


License statusAuthorised
Licence Issued05/01/2018
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceSupply through pharmacies and promotion to the public only if compliant with the following restrictions: maximum strength: 200 mg; maximum pack size 50; maximum dose: 400 mg; maximum daily dose 1200 mg; limited indications.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back